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ABSTRACT Age-related macular degeneration (AMD) is the leading cause of blindness in ageing societies, triggered by both
environmental and genetic factors. The strongest genetic signal for AMD with odds ratios of up to 2.8 per adverse allele was found
previously over a chromosomal region in 10q26 harboring two genes, ARMS2 and HTRA1, although with little knowledge as to which
gene or genetic variation is functionally relevant to AMD pathology. In this study, we analyzed rare recombinant haplotypes in 16,144
AMD cases and 17,832 controls from the International AMD Genomics Consortium and identiﬁed variants in ARMS2 but not HTRA1 to
exclusively carry the AMD risk with P-values between 1.0 3 102773 and 6.7 3 1025. This now allows prioritization of the gene of
interest for subsequent functional studies.
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AGE-RELATED macular degeneration (AMD) is a preva-lent cause of severe vision loss in ageing societies with a
strong component of genetic predisposition. Genome-wide
association studies (GWASs) and large-scale resequencing
initiatives have identiﬁed a large number of single nucleotide
variants (SNVs) enriched in complement and complement-
related genes that confer a strong risk for AMD. Recently,
the International AMD Genomics Consortium (IAMDGC)
(Fritsche et al. 2016) reported 34 independent AMD risk loci,
together explaining 50% of disease heritability.
Among the strongest loci associated with AMD are the
complement factor H (CFH) locus on chromosome 1q32 and a
region on chromosome 10q26 harboring two genes, namely
age-related maculopathy susceptibility 2 (ARMS2) and HtrA
serine peptidase 1 (HTRA1) (Jakobsdottir et al. 2005; Rivera
et al. 2005). While the causative genes at the CFH site appear
undisputed, the ARMS2/HTRA1 region proved notoriously
difﬁcult to dissect by statistical means as the chromosomal
region displays correlated variants in high linkage disequilib-
rium (LD) (Dewan et al. 2006; Fritsche et al. 2008; Kanda
et al. 2010; Yang et al. 2010; Friedrich et al. 2011, 2015). In
addition, as both ARMS2 and HTRA1 harbor functional vari-
ants that can be related to relevant disease processes, so far it
is unclear to which gene the observed disease association can
functionally be attributed (Dewan et al. 2006; Fritsche et al.
2008; Cheng et al. 2013; Friedrich et al. 2015).
Despite the strong LD in the ARMS2/HTRA1 interval, the
region still exhibits some level of recombination, resulting in
rare recombinant haplotypes. Similar to gene mapping in
monogenic diseases, recombinant haplotypes can be helpful
in dissecting a disease-associated genomic region. To this
end, we used the currently largest data set on AMD genetics
including .33,000 genotyped individuals (Fritsche et al.
2016) and analyzed the rare, but informative recombinant
haplotypes on 10q26 to deﬁne a minimal set of variants as-
sociated with AMD.
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Materials and Methods
Ethics statement
The study followed the tenetsof theDeclarationofHelsinki and
was approved by the local ethics review board at participating
sites, as previously described (Fritsche et al. 2016). Informed
written consent was obtained from each patient after explana-
tion of the nature and possible consequences of the study.
Study data and data availability
The genotypes of this study are available from theDatabase
of Genotypes and Phenotypes (dbGAP) under accession
phs001039.v1.p1 while GWAS summary statistics are
available at http://amdgenetics.org/. Our data consist of
16,144 late-stage AMD cases and 17,832 AMD-free con-
trols from European ancestry, all unrelated, as published
previously (Fritsche et al. 2016). Inclusion and exclusion
criteria as well as detailed information on ophthalmolog-
ical grading and quality control of genetic data and imputation
are given elsewhere (Fritsche et al. 2016). Genotyping and
imputation using the 1000 Genomes (1000G) reference
panel (Abecasis et al. 2012) was performed as described pre-
viously (Fritsche et al. 2016). Brieﬂy, we extracted the geno-
types of all variants in the ARMS2/HTRA locus, deﬁned as the
region of 1.25 million base pairs (bp) around the previously
described lead variant rs3750846. The extracted genotypes
were phased with ShapeIt2 following standard settings
(O’Connell et al. 2014). The resulting haplotypes were then
used for imputation with IMPUTE2 (Rahpeymai et al. 2006),
utilizing the 1000G reference panel. Upon imputation,
IMPUTE2 generates best-guess imputed haplotypes, which
can be outputted using the -haps command. In addition,
the imputed genotypes were coded as dosage data ranging
from 0 to 2 for single variant association testing as well
as mediation analyses. In total, 3,446 variants were either
genotyped or could be imputed reliably in the ARMS2/
HTRA1 region.
Several DNA specimens had been genotyped after whole
genome ampliﬁcation (WGA). To account for possible con-
founding effects of WGA, a categorical variable “WGA” was
computed, indicating the presence or absence of WGA in all
samples. Additionally, the ﬁrst two principle components
(PC1 and PC2) were computed from all genotyped variants
as described previously (Fritsche et al. 2016). All logistic re-
gression models were adjusted for WGA and PC1 and PC2 to
account for different DNA source and potential population
stratiﬁcation.
Searching for additional signals at the ARMS2/
HTRA1 locus
All statistical procedures were carried out as implemented in
R. Step-wise conditional logistic regression analysis on the
imputed dosages was used previously and failed to detect
additional independent signals at the ARMS2/HTRA1 locus
(Fritsche et al. 2016). We also aimed to exclude the possi-
bility that the main signal represented by rs3750846 was
explained by two causal variants where the risk-carrying
alleles are inherited together with one of the rs3750846
alleles. In such a scenario, the two causal variants would
represent two or more haplotypes, which would be tagged
by one of the alleles of rs3750846 (Grassmann et al. 2012;
Fritsche et al. 2016). We used mediation analysis to test
each pair of variants in the region for jointly explaining
the main signal: the b-estimate of the main variant (the
rs3750846) in a logistic regression model without adjusting
for the pair is compared to the respective b-estimate with
adjusting for the pair of variants (Imai et al. 2010), using the
mediate function from the mediation package in R (Tingley
et al. 2014).
For all analyses, we utilized the genotypes determined
experimentally or the dosages in the case of imputed var-
iants. In the case of a signiﬁcantmediation, the effect size of
the main variant would be expected to drop strongly and
signiﬁcantly. To obtain reliable nonparametric P-value
estimates, we calculated 1000 bootstrap replicates and
adjusted the resulting P-values according to the false dis-
covery rate. To reduce the complexity of the mediation
analysis, we ﬁrst extracted variants in linkage with
rs3750846 by computing D9 using the haplotypes obtained
from the imputed genotypes and extracted all variants with
D9 . 0.8. This should effectively capture the relevant com-
mon haplotypes tagged by rs3750846.
Best-guess haplotype association analyses
To further investigate the AMD-associated haplotypes at the
ARMS2/HTRA1 locus, we extracted the relevant variants. To
capture themost likely causal variant (van de Bunt et al. 2015),
we included variants that were correlated to rs3750846 (R2.
0.8) as well as all variants that were included in the 99%
credible set of associated variants (Maller et al. 2012;
Fritsche et al. 2016). The 99% credible set of associated vari-
antswas computed from theZ-scores of all variants at this locus
(Kichaev et al. 2014), effectively capturing the variants with
the strongest evidence for association. The best-guess haplo-
types deﬁned by these variants (i.e., haplotypes that carry al-
leles of these variants) were investigated for their association
with AMD using multivariable logistic regression models in-
cluding all haplotypes with reasonable counts ($34) in the
study sample except the nonrisk allele-carrying haplotype
(H0), which served as reference. We assessed the association
of the haplotypes using a logistic regressionmodel including all
haplotypes. Haplotype H0, which carried exclusively nonrisk-
increasing alleles served as baseline. We excluded variants to
be disease associated if either the nonrisk-increasing alleles
(protective alleles) of the variant were present on haplotypes
that increase the risk for AMD or if the risk-increasing alleles
were present on protective haplotypes or on haplotypes not
associated with AMD.
Accounting for phase uncertainty
To determine haplotype phase, the calculation of several
plausible haplotypes for each individual is required. This
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process is repeated many times and eventually returns the
best-guess haplotypes for each individual. It thus is possi-
ble that the estimated best-guess haplotypes are only
slightly more likely than other haplotypes and that random
effects may come into play. To account for this uncertainty,
we repeated the phasing of the haplotypes and the sub-
sequent imputation of the ARMS2/HTRA1 locus 100 times
and mapped the occurrence of the resulting haplotypes to
the best-guess haplotypes. As such, each individual is
characterized by the frequency or dosage of the 13 haplo-
types (ranging from 0 to 2). The haplotype dosages were
then analyzed for their association with AMD using the
function haplo.glm from the package haplo.stats in R
(Lake et al. 2003).
Data availability
The authors state that all data necessary for conﬁrming the
conclusions presented in the article are represented fully
within the article.
Results
The present study included 16,144 late-stage AMD cases and
17,832 AMD-free controls with both groups of European
ancestry (Fritsche et al. 2016). Variant and sample quality
control as well as imputation based on the 1000G refer-
ence panel (Abecasis et al. 2012) was reported previously
(Fritsche et al. 2016). Variant rs3750846 residing within in-
tron 1 of ARMS2 exhibited the strongest association with
AMD on 10q26 and is referred to as lead variant (Fritsche
et al. 2016). We deﬁned the ARMS2/HTRA1 locus as a region
within 1.25 million base pairs around rs3750846 to assure
the capture of all potentially correlated and associated
variants.
Initially, we explored the number of causal variants
explaining the association signal at ARMS2/HTRA1. When
applying stepwise logistic regression as described previ-
ously (Fritsche et al. 2016), there was only one but no
independent second signal at this locus. There was also
no pair of variants that jointly explained the main signal
when applying mediator analyses. Together, these ﬁnd-
ings suggested that the association at this locus was con-
ferred to by a single haplotype tagged by the lead variant
rs3750846.
We then narrowed the region of interest by haplotype
analysis focusing on highly correlated variants. The best-
guess haplotypes for the locus were derived and their
complexity was reduced by focusing on 25 variants that
were (i) highly correlated with rs3750846 (R2. 0.8) or (ii)
in the 99% credible set of associated variants (Maller et al.
Table 1 Candidate variants at the ARMS2/HTRA1 locus on 10q26 correlated with rs3750846 (R2 > 0.8) or part of the 99% credible set of
associated variants
Position on
Chr. 10 (bp) rs ID
Nonrisk
allele
Risk
allele
Location/
consequence
2Log10
P-value PPAa R2b D9b
OR
(95% C.I.)c Excluded
124,203,787 rs61871744 T C Intergenic 741.2 1.83310242 0.952 0.995 2.787 (2.693;2.885) Yes
124,209,684 rs11200630 T C Intergenic 774.5 3.5631029 0.989 0.999 2.798 (2.706;2.894) Yes
124,210,369 rs61871745 G A Intergenic 780.4 0.003 0.996 0.999 2.804 (2.711;2.900) No
124,211,536 rs11200632 A G Intergenic 780.2 0.002 0.998 0.999 2.796 (2.703;2.891) No
124,211,596 rs11200633 C T Intergenic 780.3 0.002 0.998 0.999 2.795 (2.703;2.890) No
124,212,913 rs61871746 T C Intergenic 781.3 0.024 0.998 1.000 2.794 (2.702;2.889) No
124,213,046 rs61871747 C T Intergenic 781.5 0.033 0.998 1.000 2.793 (2.701;2.888) No
124,214,448d rs10490924 G T ARMS2: p.A69S 781.8 0.076 0.998 1.000 2.786 (2.694;2.881) No
124,214,600 10:124214600 G GGT ARMS2: intronic 781.9 0.091 0.998 1.000 2.787 (2.695;2.881) No
124,214,976 rs36212731 G T ARMS2: intronic 781.9 0.094 0.999 1.000 2.787 (2.695;2.881) No
124,215,198d rs36212732 A G ARMS2: intronic 781.9 0.085 0.999 1.000 2.786 (2.695;2.881) No
124,215,211 rs36212733 T C ARMS2: intronic 782.0 0.110 0.999 1.000 2.787 (2.695;2.881) No
124,215,315 rs3750848 T G ARMS2: intronic 782.1 0.139 0.999 1.000 2.787 (2.695;2.882) No
124,215,421d rs3750847 C T ARMS2: intronic 782.2 0.168 0.999 1.000 2.787 (2.695;2.882) No
124,215,565 rs3750846 T C ARMS2: intronic 782.2 0.173 1.000 1.000 2.787 (2.695;2.882) No
124,216,820 esv2663177 443 bp 54 bp ARMS2: UTR
del442ins54
770.0 1.02310213 0.981 0.991 2.762 (2.671;2.856) Yes
124,219,275d rs3793917 C G Intergenic 768.0 1.10310215 0.979 0.990 2.756 (2.665;2.849) Yes
124,220,061 rs3763764 A G Intergenic 759.6 4.05310224 0.965 0.989 2.746 (2.656;2.839) Yes
124,220,544d rs11200638 G A HTRA1: Promoter 755.9 9.29310228 0.963 0.988 2.737 (2.647;2.830) Yes
124,221,270 rs1049331 C T HTRA1: p.A34A 755.6 5.06310228 0.961 0.987 2.744 (2.654;2.838) Yes
124,221,276 rs2293870 G T HTRA1: p.G36G 755.5 3.44310228 0.961 0.987 2.744 (2.654;2.838) Yes
124,226,630 rs2284665 G T HTRA1: intronic 742.4 3.10310241 0.933 0.974 2.724 (2.634;2.817) Yes
124,230,024 rs58077526 A C HTRA1: intronic 716.7 5.71310267 0.896 0.958 2.672 (2.584;2.763) Yes
124,231,464 rs932275 G A HTRA1: intronic 716.7 5.23310267 0.899 0.962 2.678 (2.590;2.770) Yes
124,234,037 rs2142308 G C HTRA1: intronic 711.1 1.45E272 0.888 0.956 2.666 (2.578;2.756) Yes
a Posterior probability of association.
b Linkage to the top variant rs3750846.
c Odds ratio and 95% C.I. of risk increasing allele.
d Directly genotyped variant.
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2012; van de Bunt et al. 2015; Fritsche et al. 2016) (Table 1).
This resulted in 13 haplotypes that were counted at least
34 times in the study sample and thus resulted in a haplo-
type frequency $0.05% (Figure 1). Twelve haplotypes
were included in a haplotype association analysis by lo-
gistic regression modeling with the common nonrisk al-
lele representing haplotype H0 as reference (Figure 1).
As expected, the common haplotype carrying all risk-
increasing alleles (H12) was strongly associated with
AMD (P , 10250).
Two additional ﬁndings were of particular interest when
focusing on the rare recombinant haplotypes: (1) haplotypes
H1–H4 with risk-increasing alleles exclusively at the vari-
ants downstream of rs3750846 were not associated with
AMD (P . 0.05) (Figure 1), while (2) haplotypes H7–H11
with the nonrisk alleles at the variants downstream of
rs3750846 were highly signiﬁcantly associated with AMD
(P from ,10250 to 6.68 3 1025). In addition, the ﬁrst two
variants upstream of ARMS2 (rs61871744 and rs11200630)
were also not associated with AMD, since haplotypes without
the risk-increasing alleles at the two variants were associated
with increased disease risk. Together, these ﬁndings reveal
that variants downstream of the lead variant rs3750846 do
not contribute to AMD risk and that the most likely candidates
driving the AMD association are 13 variants in and immedi-
ately upstream of the ARMS2 gene. A further narrowing of the
reﬁned AMD-associated interval would require an even larger
data set due to the low rate of recombination between the local
variants at and around ARMS2.
Our estimation of haplotypes and subsequent imputations
relied on the calculation of best-guess haplotypes derived from
several likely haplotypes calculated over several (internal)
iterations. However, some of those recombinant haplotypes
could in fact be better represented by less likely haplotypes,
which were not chosen initially due to random effects. We
therefore repeated the phasing and imputation 100 times to
account for phasing uncertainty. The resulting haplotype oc-
currences were mapped to the 13 best-guess haplotypes and
analyzed using logistic regression. The results of this analysis
were similar to the results obtained from the best-guess hap-
lotypes (Supplemental Material, Table S1), indicating that the
reconstructed best-guess haplotypes are robust and likely rep-
resent the true haplotype structure in our cohort.
Discussion
Since its initial reporting, the ARMS2/HTRA1 region has been
a point of controversy as to which gene is causally linked to
Figure 1 Delineating associated haplotypes at the ARMS2/HTRA1 locus. Shown are 13 haplotypes deﬁned by 25 variants that were either correlated
with the lead variant rs3750846 (R2 . 0.8) or in the 99% credible set of associated variants (Fritsche et al. 2016) (see also Table 1). P-values are given
based on a logistic regression model including H1–H12 as covariates and H0 carrying exclusively nonrisk alleles as reference. AMD risk-increasing alleles
are colored in red and the protective alleles in blue. In the case in which a haplotype is carrying the risk-increasing allele of a variant but is not
signiﬁcantly associated with AMD, this variant is regarded not to be associated with disease risk. Similarly, if a haplotype carrying the protective variant
allele is increasing the risk for the disease, we concluded that this variant is not associated with AMD risk. The minimal set of risk-associated variants
(gray box) includes 13 variants not excluded by the haplotype analysis and located exclusively at the immediate ARMS2 locus. Thin dark blue boxes
represent the UTR; thick dark blue boxes represent the coding region of ARMS2 as well as the ﬁrst exon of HTRA1. Gene sizes and relative positions are
not to scale. Intronic sequences are given by dark blue arrows indicating the direction of transcription. Each square as part of a haplotype represents a
single variant, ordered by chromosomal position from centromere (left) to telomere (right) (see also Table 1). Also shown is the number of observed best-
guess haplotypes (N), the odds ratio (OR), and 95% conﬁdence intervals (95% C.I.) as well as the frequency of the best-guess haplotypes H0–H12 in
cases and controls.
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AMD pathogenesis (Yang et al. 2006; Fritsche et al. 2008;
Kanda et al. 2010; Friedrich et al. 2011). Our analysis of
recombinant haplotypes in the currently largest available
data set of AMD patients and controls has now reﬁned the
associated interval pointing to associated variants close to
ARMS2 but excluding variants near the HTRA1 locus from
disease association. In particular, the two synonymous vari-
ants in the ﬁrst exon ofHTRA1 as well as theHTRA1 promoter
variant rs11200638 were excluded from AMD association,
making it rather unlikely that HTRA1 plays a signiﬁcant caus-
ative role in AMD pathogenesis. This is also true for AMD-
associated HTRA1 variants rs1049331 and rs2293870,
previously reported to strongly inﬂuence gene transcription
(Yang et al. 2006) and more importantly its ability to bind
insulin-like growth factor 1 (Jacobo et al. 2013) or to regulate
TGFb signaling (Friedrich et al. 2015).
Interestingly, thecomplexvariantevs2663177(del443ins54),
which is locatedwithin the 39-untranslated region (UTR) of
ARMS2 and which has been shown to inﬂuence stability of
the ARMS2 transcript (Fritsche et al. 2008), was also ex-
cluded by our analysis as being AMD associated. Therefore,
a mechanism other than haploinsufﬁciency needs to be
considered as disease related, involving the ARMS2 gene
product. In line with this is an earlier notion emphasizing
that variant ARMS2:rs2736911 resulting in a truncated
ARMS2 protein (R38X) was never found to be associated
with AMD (Friedrich et al. 2011), challenging the possibil-
ity of ARMS2 protein deﬁciency to have a role in AMD
pathology.
In light of our ﬁndings, the most likely functional variant
left is rs10490924 (p.A69S) in theARMS2 gene. Although this
variant does not seem to strongly inﬂuence localization, sta-
bility, or expression of ARMS2 (Kanda et al. 2007;Wang et al.
2009; Kortvely et al. 2010), other data suggest that it could
inﬂuence cell attachment in vitro (Cheng et al. 2013). Nev-
ertheless, the true function and localization of ARMS2 still
remains unclear, although our ﬁndings may put a new
emphasis on clarifying the role of ARMS2 in the retina
and, speciﬁcally, on testing functional consequences of the
p.A69S polymorphism.
In conclusion, we demonstrate that genetic variants in or
close to ARMS2 but not HTRA1 are responsible for disease
susceptibility at the 10q26 locus. This ﬁnding will help to
focus the functional analysis on ARMS2 and its role in AMD
pathogenesis.
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